LOS ANGELES, April 12 /PRNewswire-USNewswire/ -- Aptium Oncology, Inc. today announced the launch of Aptium Oncology Myeloma Consortium (AMyC), a broad-based collaboration that brings together renowned investigators to work with pharmaceutical sponsors to advance clinical and translational research in myeloma and related cancers.
Brian G.M. Durie, M.D., Director, Myeloma
Consortium for Aptium Oncology and an internationally recognized expert
in multiple myeloma, heads the consortium of investigators and
institutions across the United States.
Co-founder of the International Myeloma Foundation (IMF), Dr. Durie is a
world-renowned expert in multiple myeloma, as well as highly respected
researcher, professor, author and recipient of numerous awards... read more